Advances in Neuroprotective Ingredients of Medicinal Herbs by Using Cellular and Animal Models of Parkinson’s Disease
Open Access
- 1 September 2013
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-15
Abstract
Parkinson’s disease (PD) is a multifactorial disorder, which is neuropathologically identified by age-dependent neurodegeneration of dopaminergic neurons in the substantia nigra. Development of symptomatic treatments has been partly successful for PD research, but there remain a number of inadequacies in therapeutic strategies for the disease. The pathogenesis of PD remains intricate, and the present anti-PD treatments appears to be clinically insufficient. Comprehensive research on discovery of novel drug candidates has demonstrated that natural products, such as medicinal herbs, plant extracts, and their secondary metabolites, have great potential as therapeutics with neuroprotective activity in PD. Recent preclinical studies suggest that a number of herbal medicines and their bioactive ingredients can be developed into optimum pharmaceuticals for treating PD. In many countries, traditional herbal medicines are used to prevent or treat neurodegenerative disorders, and some have been developed as nutraceuticals or functional foods. Here we focus on recent advances of the evidence-linked neuroprotective activity of bioactive ingredients of herbal origin in cellular and animal models of PD research.Keywords
This publication has 111 references indexed in Scilit:
- Gastrodin Protects Apoptotic Dopaminergic Neurons in a Toxin-Induced Parkinson’s Disease ModelEvidence-Based Complementary and Alternative Medicine, 2013
- Discovery of curcumin, a component of golden spice, and its miraculous biological activitiesClinical and Experimental Pharmacology and Physiology, 2011
- Ethanol extract of Scutellaria baicalensis Georgi prevents oxidative damage and neuroinflammation and memorial impairments in artificial senescense miceJournal of Biomedical Science, 2011
- A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesiasParkinsonism & Related Disorders, 2010
- Baicalein reduces E46K α‐synuclein aggregation in vitro and protects cells against E46K α‐synuclein toxicity in cell models of familiar ParkinsonismJournal of Neurochemistry, 2010
- Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell modelBMC Neuroscience, 2010
- Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF‐I receptor signalling pathwayBritish Journal of Pharmacology, 2009
- Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in ratsJournal of Biomedical Science, 2009
- Plant-derived compounds in clinical trialsDrug Discovery Today, 2008
- Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1receptorBritish Journal of Pharmacology, 2006